Tech Focus Guyana: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Focus Guyana.

Press releases published on October 22, 2026

Oct. 22, 2026

SEON and Merchant Risk Council to Host Webinar on Detecting AI Agent Fraud

Indeterminate GlobeNewswire

Oct. 22, 2026

red violet Debuts on Fortune’s 2026 Fastest-Growing Companies List at No. 43

Indeterminate GlobeNewswire

Oct. 22, 2026

SCYNEXIS Completes Phase 1 Study of Intravenous SCY-247, a Novel, Triterpenoid Antifungal in Development for Treatment and Prevention of Invasive Fungal Diseases

Indeterminate GlobeNewswire

Oct. 22, 2026

Replimune to Report the Fiscal Second Quarter 2027 Financial Results and Provide Corporate Update on October 28, 2026

Indeterminate GlobeNewswire

Oct. 22, 2026

Verrica Pharmaceuticals Announces Achievement of Milestones Unlocking Access to the Full $27.5 Million of Non-Dilutive Growth Capital Under Credit Facility

Indeterminate GlobeNewswire

Oct. 22, 2026

Eos SENOLYTIX Presents Late-Life Survival and Healthspan Data for Mitochondria-Targeted Geropeptide PTC-2105 at the 17th World Congress on Targeting Mitochondria, and Launches “Team Speedy” to Let the Public Follow Its Longest-Lived Mouse

Indeterminate GlobeNewswire

Oct. 22, 2026

Aduro Clean Technologies to Engage Industry and Institutional Investors at Five Conferences Through Year-End 2026

Indeterminate GlobeNewswire

Oct. 22, 2026

Rgenta Therapeutics Announces Successful End-of-Phase 2 Meeting with FDA and Alignment on Phase 3 Trial Design for RGT-61159 in Patients with Adenoid Cystic Carcinoma (ACC)

Indeterminate GlobeNewswire

Oct. 22, 2026

4Tissue raises €7 million in Series A financing and appoints Stéphanie Dupont as CEO

Indeterminate GlobeNewswire

Oct. 22, 2026

MIRA Pharmaceuticals Reports MIRA-55 Demonstrated Significant Pain Relief Comparable to Celebrex in Chronic Inflammatory Pain Study

Indeterminate GlobeNewswire

Oct. 22, 2026

AskBio Announces 5 Presentations at the European Society of Gene and Cell Therapy (ESGCT) 33rd Annual Congress

Indeterminate GlobeNewswire

Oct. 22, 2026

Krystal Biotech to Report Third Quarter 2026 Financial Results on November 2, 2026

Indeterminate GlobeNewswire

Oct. 22, 2026

NordPass launches Identity Masking and ID Monitoring

Indeterminate GlobeNewswire

Oct. 22, 2026

GPGI Announces Date of Third Quarter 2026 Earnings Release and Conference Call

Indeterminate GlobeNewswire

Oct. 22, 2026

NeOnc Technologies to Be Featured on Health Uncensored with Dr. Drew to Discuss Reaching Brain Tumors Without Surgery or Systemic Chemotherapy

Indeterminate GlobeNewswire

Oct. 22, 2026

ThoughtSpot stellt AgentSpot vor: Von Chatbots zur Multiplayer-KI

Indeterminate GlobeNewswire

Oct. 22, 2026

Corbus Pharmaceuticals to Present Late Breaking CRB-913 Data from Canyon-1 Study at Obesity Week® 2026

Indeterminate GlobeNewswire

Oct. 22, 2026

Rectify to Present Translational Data Supporting RTY-406 as a Transformative Therapy for PSC and Other Hepatobiliary Diseases

Indeterminate GlobeNewswire

Oct. 22, 2026

Teads to Release Third Quarter 2026 Financial Results on November 5, 2026

Indeterminate GlobeNewswire

Oct. 22, 2026

Climb Global Solutions Acquires NeoVAD, Building Greater Scale in France

Indeterminate GlobeNewswire